Skip to main content
. 2014 Oct 13;9(10):e109623. doi: 10.1371/journal.pone.0109623

Figure 13. Optimal dosing based on leukocyte count as target.

Figure 13

A. Evolution of leukocyte count in response to optimum 6-MP dosing. Dashed line represents critical leukocyte level and solid dots represent clinical data for an average patient. B. Optimum 6-MP dosing profile predicted by NMPC. The standard daily 6-MP dosing is 75 mg/day.